siRNA in vivo Delivery Kit (BT-000002)

* This product is for research use only. Not intended for use in the treatment or diagnosis of disease.

Product Information
Catalog Number BT-000002
Appearance Colorless.
Application RNA interference in vivo
Storage On first use, aliquot reagent and store at -80°C. Thawed aliquots can be refrigerated for up to 1 week or frozen for long-term storage. Do not dilute reagent.
Brief Introduction BOC Sciences offers siRNA in vivo delivery kits that are powerful for in vivo studies of gene function and RNA interference. This reagent is made of our proprietary formula to directly deliver small interfering RNA (siRNA) into cells and achieve efficient siRNA transfection. In addition to user-friendly in vivo delivery, this formulation protects nucleic acids from lysosomal degradation and efficiently releases nucleic acids from lysosomes to ensure maximum functionality. No significant pro-inflammatory response was detected with reagent. Our siRNA in vivo delivery kit can be administered by systemic or local injections and is the best choice for in vivo delivery of siRNA.
Cell Types Cells in vivo
  • No animal-derived components.
  • Efficient transfection with low siRNA concentration.
  • Efficient transfection of primary cells with high cell viability.
  • Efficient transfection of suspension cells and macrophages.
  • Greater than 90% knockdown efficiency with various cell types.
  • Compatible with serum-containing or serum-free medium, no need for medium replacement before or after transfection.
  • Low toxicity, no obvious pro-inflammatory response
  • All products are functionally verified.
Form Colorless liquid.
Identification No nuclease pollution and microbial pollution
Recommended Usage Systemic or local injection.
Shipping RT or on wet ice.
Transfection Sample Type siRNA
Use Limitations For research use only. Not suitable for any diagnostic or therapeutic use.
Description Reagents designed for siNA in vivo transfection.
References 1.Osborn MF; et al. Improving siRNA Delivery In Vivo Through Lipid Conjugation. Nucleic Acid Ther. 2018; 28(3): 128-136.

Related Products